doi: 10.1542/peds.2008-1573.
Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder
- PMID:18676566
- DOI: 10.1542/peds.2008-1573
Item in Clipboard
Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder
James M Perrin et al. Pediatrics.2008 Aug.
Display options
Format
Display options
Format
No abstract available
Similar articles
- Cardiovascular safety of medication treatments for attention-deficit/hyperactivity disorder.Newcorn JH, Donnelly C.Newcorn JH, et al.Mt Sinai J Med. 2009 Apr;76(2):198-203. doi: 10.1002/msj.20096.Mt Sinai J Med. 2009.PMID:19306385No abstract available.
- Stimulants for kids with ADHD--how to proceed safely.Ken Mehta S, Jacobs I.Ken Mehta S, et al.J Fam Pract. 2014 Feb;63(2):E1-5.J Fam Pract. 2014.PMID:24527478
- Stimulants and sudden death: what is a physician to do?Wilens TE, Prince JB, Spencer TJ, Biederman J.Wilens TE, et al.Pediatrics. 2006 Sep;118(3):1215-9. doi: 10.1542/peds.2006-0942.Pediatrics. 2006.PMID:16951018Review.
- [Treatment with central nervous system stimulants. Practical guidelines].Hvolby A, Jørgensen JI.Hvolby A, et al.Ugeskr Laeger. 2004 Jan 12;166(3):144-8.Ugeskr Laeger. 2004.PMID:14870640Danish.No abstract available.
- Safety of stimulant treatment in attention deficit hyperactivity disorder: part II.Merkel RL.Merkel RL.Expert Opin Drug Saf. 2010 Nov;9(6):917-35. doi: 10.1517/14740338.2010.503238.Expert Opin Drug Saf. 2010.PMID:20615078Review.
Cited by
- Efficacy and safety of atomoxetine in the treatment of children and adolescents with attention deficit hyperactivity disorder.Kohn MR, Tsang TW, Clarke SD.Kohn MR, et al.Clin Med Insights Pediatr. 2012 Nov 5;6:95-162. doi: 10.4137/CMPed.S7868. Print 2012.Clin Med Insights Pediatr. 2012.PMID:23641171Free PMC article.
- Taking the stress out of individualizing ADHD drug therapy.McLeod M, Laubscher T, Regier L, Jensen B.McLeod M, et al.Can Fam Physician. 2009 Sep;55(9):895-8.Can Fam Physician. 2009.PMID:19752258Free PMC article.No abstract available.
- An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults.Wilens TE, Morrison NR, Prince J.Wilens TE, et al.Expert Rev Neurother. 2011 Oct;11(10):1443-65. doi: 10.1586/ern.11.137.Expert Rev Neurother. 2011.PMID:21955201Free PMC article.Review.
- Attention Deficit Hyperactivity Disorder in Pediatric Patients with Pheochromocytoma and Paraganglioma.Batsis M, Dagalakis U, Stratakis CA, Prodanov T, Papadakis GZ, Adams K, Lodish M, Pacak K.Batsis M, et al.Horm Metab Res. 2016 Aug;48(8):509-13. doi: 10.1055/s-0042-106725. Epub 2016 May 12.Horm Metab Res. 2016.PMID:27171833Free PMC article.
- Expanding medication options for pediatric ADHD.Froehlich TE, Delgado SV, Anixt JS.Froehlich TE, et al.Curr Psychiatr. 2013 Dec;12(12):20-29.Curr Psychiatr. 2013.PMID:25598746Free PMC article.No abstract available.
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical